Hikma Pharmaceutical reported 248M in Net Income for its first fiscal semester of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
AstraZeneca AZN:LN 550M 1011M
Bayer BAYN:GR € -2335M 4424M
Fresenius FRE:GR € 471M 36M
Galapagos GLPG:NA € -64.33M 73.69M
Genmab GEN:DC DK 306M 790M
GlaxoSmithKline GSK:LN 1395M 322M
GRIFOLS GRF:SM € 136.88M 6.94M
H. Lundbeck A/S LUN:DC 378M 243M
Hikma Pharmaceutical HIK:LN 248M 29M
Lonza Group LONN:SW 319M 73M
Merck MRK:GR € 745M 2M
Orion ORNBV:FH € 56M 3.5M
Recordati REC:IM € 117.21M 27.34M